Cannon received his B.A., M.A. and Ph.D. from the University of Tennessee, Knoxville. He is an Assistant Research Professor in the Department of Psychology and director of the clinical neuroscience laboratory at UT and director of the cognitive neuroscience laboratory at the Cole Neuroscience Center, located at the University of Tennessee Memorial Medical Center. He completed his Ph.D. in experimental psychology with an emphasis in neuroscience methods, neurophysiology and biological psychology. He is author of several book chapters and has published numerous neuroscience papers in peer-reviewed journals, including the first work demonstrating that human beings can learn to change the electrical activity in specific regions within the cortex using spatial specific neuro-operant learning. Cannon has received awards for research presentations and was recently nominated by the National Institute of Drug Abuse for a young investigator award. He has collaborated on a book chapter about the efficacy of neurofeedback for treatment of substance use disorders, and is developing statistical models for reporting psychotherapy and addiction treatment efficacy. He received several awards during his graduate training, including the Cureton Award for outstanding scholarship in the areas of psychometrics and neuropsychology. Cannon has presented research at Columbia University and Harvard Medical School. More recently, he has introduced a standard protocol for assessing treatment outcomes for psychiatric syndromes. He has developed chemical dependency assessment instruments and a treatment model incorporating standardized group therapy and spatial-specific neurofeedback training.

Prof.Dr. Mustafa Nazıroğlu has received his PhD (Physiology) in Fırat University during the period  of 1992-1996.  Currently, he is working as Head of Department of Biophysics in Suleyman Demirel University (SDU), Medical Faculty. He has successfully completed his administrative responsibilities as Head of department, Head of Congress organization committee, director of Neuroscience Research Center in SDU. As chair of congress, he organized 1st, 2cd and 3th biennale International Congress in Cell Membrane and Oxidative Stress: Focus on Calcium Signaling and TRP channels between 2006-2010, Isparta, Turkey. (www.cmos.org.tr). He is also serving in organization committee of TEMA-14 Congress (2011), Hubei, Chine. He is serving as an editorial member of several reputed journals like ‘Biological Trace Element Research’, ‘Cell Membranes and Free Radical Research, ‘Turkish Journal of Medical Sciences’. He is also review editor in Frontiers in Membrane Physiology and Biophysics. He authored 105 international research articles and 1023 citation in SCI and 5 international book chapters. He is a member of Cell Membranes and Free Radical Society (Head of the society), Turkish Physiological Society and International Brain Research Organization (IBRO). He has honored as ‘Young Investigative Scientist Award (2001), UC-Berkeley, USA, Alexander von Humboldt (AvH) Research fellowship owner (2002-2005), RWTH-Aachen, Germany, Encouragement Award of Scientific and Tech. Res. Council (TUBITAK), Ankara, Turkey (2006), Howard Hudges Medical Institute (USA) support (2009).
 

Marks Education went on in Boston University School of Medicine Boston Massachusetts Ph.D in Biochemistry University of Massachusetts Amherst Massachusetts B.S in Zoology

Yasumasa Graduated in Kyushu University School of Medicine, Fukuoka, Japan, Resident, Department of Neurology, Kyushu University Hospital Neurologist, National Beppu Hospital, Oita, Japan, Research fellow, National Institute of Neuroscience, NCNP, Tokyo, Resident, Department of Neurology, Kyushu University Hospital, Visiting Scientist, Case Western Reserve University, Cleveland, OH, USA, Visiting Scientist, Mayo Clinic Jacksonville, Jacksonville, FL, USA, Neurologist, Department of Neurology, Iizuka Hospital, Fukuoka, Research Associate, Department of Neurology, Kyushu University, Assistant Professor, Department of Neurology, Kyushu University, Associate Professor, Department of Neurology, Kyushu University

Mikko’s education of MSc, Biotechnology (1995); Department of Biochemistry and Biotechnology, Faculty of Natural Sciences and Environmental Sciences, Kuopio University, Finland, PhD, Neuroscience (2001); Department of Neuroscience and Neurology, Faculty of Medicine, Kuopio University, Finland. Doctoral thesis in the field of neuroscience: “A molecular genetic study of factors involved in Alzheimer’s disease" Docent (Adjunct Professor), Molecular genetics (2005); Faculty of Medicine, Kuopio University, Finland

Chohan is working in the department of neurosurgery at university of New Mexico Hospital and was invited as Guest Editor for a special issue entitled Novel Approaches to Alzheimers Disease Therapeutics for the Journal of Alzheimer Disease 2008 he obtained World Association of Alzheimer Disease Scientists WAADS Award 2005
 

Dr. Head received a M.A in Psychology and a Ph.D. in Neuroscience from the University of Toronto, Canada.  She received postdoctoral training at the Institute for Brain Aging & Dementia at the University of California – Irvine. She was co-leader of the Neuropathology Core of the University of California Irvine Alzheimer’s Disease Research Center and was Director of the Institute’s Brain Bank. Dr. Head moved to UK in January of 2009 and is currently an Associate Professor at the Sanders-Brown Center on Aging.  The focus of Dr. Head’s research team is to identify interventions in animal models that may prevent the onset and/or progression of Alzheimer disease in Down syndrome and in the general population.
 

Colin had his Ph.D. from the University of Rochester in the Department of Neurobiology and Anatomy and did my post-doctoral studies in the Alzheimer Research Laboratory at Case Western Reserve University. I joined the Dept. of Pharmacology, Physiology and Therapeutics at the University of North Dakota as an Assistant Professor in 2000 and was promoted to Associate Professor in 2007. My work focuses on understanding the mechanisms that contribute to the inflammatory changes characteristic of the chronic neurodegeneration that occurs in Alzheimers and Parkinsons disease. In particular, my laboratory works to identify how the brains immune cells, microglia, may be contributing to the pathophysiology of these conditions.

Kebreten Manaye is an Associate Professor in the Department of Physiology and Biophysics at the Howard University College of Medicine where she has been a faculty member for eleven years After earning her medical degree from the University Of Aristotle School Of Medicine in Thessalonica Greece Dr Manaye joined the Department of Psychiatry at the University of Texas Southwestern Medical Center in Dallas as a postdoctoral fellow in 1986 In 1990 she became an assistant professor in the department before moving to Howard University in 1999 Her publications have appeared in journals such as the Journal of Comparative Neurology Biological Psychiatry and Neuropharmacology She is an active member of several professional organizations including American Association for the Advancement of Science AAAS the Society for Neuroscience International Alzheimer Association International Brain Research Organization and the New York Academy of Sciences She currently serves as an Associate Editor for the Journal of Alzheimer Disease and she also serves on the Board of Directors for the International Behavioral Research Press and Sinq Neuroimaging Systems Inc

Dr. Othman Ghribi is an Associate professor at the Department of Pharmacology, Physiology and Therapeutics, University of North Dakota School of Medicine and Health Sciences, USA. He obtained his Ph.D degree in Neuropharmacology from Rene Descartes University, Paris, France in 1994. He has published four book chapters, invited review papers and has more than 50 publications in different peer reviewed journals. Dr. Ghribi holds grants from the Centers of Biomedical Research Excellence and the National Institute of Environmental health Sciences/The National Institute of Health. Dr. Ghribi obtained the Alzheimers and Related Diseases Research Award from the Virginia Center on Aging as well as the Dean David Wilson Academic Award in Neuroscience from the University of North Dakota.
 

Dr. Cara Westmark is an Associate Scientist at the Waisman Center for Developmental Disabilities at the University of Wisconsin-Madison. Her current research examines the role of genetic and environmental factors on the expression of amyloid precursor protein (APP) and beta-amyloid (A beta) in transgenic mouse models of neurological disorders. She has demonstrated that APP/ A beta levels are altered in Fragile X syndrome and that many FXS phenotypes can be rescued in a mouse model of the disorder by genetically reducing APP/ A beta. These data suggest that therapies studied for the treatment of Alzheimer’s disease (AD) may be beneficial in the treatment of FXS. She has also demonstrated a strong association between APP/ A beta over-expression and lower seizure threshold, which has important implications for the treatment of seizure-related disorders such as AD, FXS and Down syndrome. Her most recent work has demonstrated a strong association between dietary phytoestrogen consumption, elevated A beta and reduced seizure threshold.
 

Dr. Videnovic obtained his MD at the University Of Belgrade School Of Medicine, where he subsequently completed an internship in Internal medicine followed by a residency in Anatomic pathology. From 1998 to 2000 he was a postdoctoral fellow in the Department of Pharmacology at the University of Illinois in Chicago, where he worked on the neurobiology of the sleep apnea syndrome. He subsequently moved to the Rush Alzheimers Disease Center in Chicago, where he worked on several NIH funded clinical-pathological studies of aging. Dr. Videnovic completed an internship in Internal medicine at MCP Hahnemann University Hospital in Philadelphia, and a Neurology residency at Northwestern University Feinberg School of Medicine in Chicago where he served as chief resident. Subsequently he trained in Movement Disorders at Rush University Medical Center in Chicago, and sleep medicine at Northwestern University. He obtained a Master of Science degree in clinical research from the Rush Graduate College in 2007. He was appointed as Assistant Professor of Neurology at Northwestern University Feinberg School of Medicine in July 2007. Dr. Videnovic is a member of the American Academy of Neurology, the Parkinson Study Group, and the American Academy of Sleep Medicine. Dr. Videnovic cares for patients with Parkinsons disease and various movement disorders. He is a principal investigator and co-investigator on several clinical trials in the field of Parkinsons disease and movement disorders. His research focuses on sleep dysfunction in neurodegenerative disorders, particularly Parkinsons disease.

Ubaldo Armato obtained Degree in Medicine & Surgery with Honors (Padua, July 1967). State qualification to medical practice (Padua, March 1968). Diploma in Haematology (Padua, November 1969), Diploma in Internal Medicine with Honours (Padua, November 1975). Full Professor of Histology & Embryology at the University of Verona Medical School (Dentistry: July 1986-October 1987; Medicine & Surgery: from November 1987 to date), Verona, Venetia, Italy. Head of the Histology and Embryology Unit, Dept. Biomedical & Surgical Sciences, Verona University from January 1999 to Januay 2009. Head of the Histology and Embryology Section, Dept. Life and Reproduction Sciences, Verona University from February 2009 to date.
 

Jesús Avila is Professor and former Director of the Center of Molecular Biology Madrid Spain During the last thirty years have been working in neuron cytoskeleton Now he studies the role of tau protein in neurodegenerative disorders tauopathies like Alzheimer disease He is member of different Organizations like EMBO European Academy and the Spanish Royal Academy of Sciences; he is member of different Editorial Boards and has more than 300 publications most of them related with Alzheimer disease

Abha Chauhan, Ph.D., is the Head of the Developmental Neuroscience Laboratory at the New York State Institute for Basic Research in Developmental Disabilities (IBR), Staten Island, New York. She is also adjunct doctoral faculty member of the Neuroscience Subprogram at the Graduate Center of the City University of New York. Dr. Chauhan received her B.S. (Chemistry Honors) in 1976 from the University of Delhi, her M.S. (Biochemistry) in 1978, and Ph.D. in 1982 from the Department of Biochemistry, Postgraduate Institute of Medical Education and Research, Chandigarh, India. From 1983 to 1984, she worked as a Research Associate at the Mount Sinai School of Medicine, New York. Dr. Chauhan then joined the Department of Neurochemistry at IBR, where she has over 60 publications in the fields of membrane biochemistry, oxidative stress, signal transduction, Alzheimer’s disease, and autism. Dr. Chauhan has been awarded research grants as a principal investigator from the Department of Defense, Autism Speaks, Autism Research Institute, and California Walnut Commission, and as a co-principal investigator from NIH. Recently, she served as the editor of the book entitled Autism: Oxidative stress, Inflammation, and Immune Abnormalities. Dr. Chauhans publications include reports on calcium traversal across membrane bilayer, the role of phosphoinositides in the activation of protein kinase C, action of amyloid beta-protein (A) on protein kinases, identification of factors influencing aggregation and fibrillization of A, interaction of A with membrane lipids and its effect on membrane properties, anti-amyloidogenic, anti-oxidant and anti-apoptotic role of gelsolin, and on oxidative stress, immune response and membrane abnormalities in autism.